首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1454159

全球快速诊断市场规模、份额、成长分析、按产品、按平台、按最终用途 - 行业预测，2024-2031 年

Global Rapid Diagnostics Market Size, Share, Growth Analysis, By product, By platform, By End use, By Application - Industry Forecast 2024-2031

出版日期: 2024年03月11日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球快速诊断市场规模为292.6亿美元，从2023年的353.9亿美元成长到2031年的16.2亿美元，预测期间（2024-2031年）复合年增长率为20.95%，预计也将成长至8000万美元。

快速诊断主要用于资源有限的医疗机构中医疗状况的初步或紧急筛检。操作简单快捷，可在初级保健环境中进行即时检测。多种传统诊断方法结合了快速诊断方法，包括快速抗体测试（例如快速HIV测试）、快速血浆试剂和快速抗原测试（例如快速流感诊断、快速疟疾抗原检测测定）。快速诊断测试广泛应用于筛检、流行病学、患者管理和诊断。推动市场扩张的关键因素是对分散环境中快速诊断的需求不断增长，以及公众对早期诊断好处的认识不断提高。此外，由于对价格实惠的准确诊断的需求不断增长，预计市场将会扩大。然而，由于消费者对市场上可用的新型快速诊断缺乏认识，快速诊断市场的成长受到阻碍。也就是说，快速诊断市场预计将受益于床边诊断需求的不断增长。照护现场快速诊断市场涵盖一系列测试工具，包括血糖监测套件、怀孕和不孕症测试套件、感染疾病测试套件、尿液测试套件、血液学测试套件、心臟代谢监测套件和类似工具。这些测试用于医院、专科诊所和私人家庭。照护现场和快速诊断领域的市场成长主要是由感染疾病的高发病率、政府支持政策以及 CLIA 豁免 POC 检查数量的增加所推动的。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Abbott Laboratories
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
ACON Laboratories, Inc.
Creative Diagnostics
Danaher Corporation
Thermo Fisher Scientific Inc.
BioMA（C）rieux SA
Alfa Scientific Designs, Inc.
BTNX Inc.
Meridian Bioscience, Inc.
and Trinity Biotech plc

简介目录

Product Code: SQMIG35A2152

Global Rapid Diagnostics Market size was valued at USD 29.26 billion in 2022 and is poised to grow from USD 35.39 billion in 2023 to USD 162.08 billion by 2031, at a CAGR of 20.95% during the forecast period (2024-2031).

Rapid diagnostic tests (RDTs) are primarily utilized for preliminary or urgent screening of medical conditions in healthcare facilities with limited resources. They enable point-of-care testing in primary care settings through simple and rapid operations. Various traditional diagnostic methods, including rapid antibody tests (e.g., rapid HIV test), rapid plasma reagin, and rapid antigen tests (e.g., rapid influenza diagnostic test and rapid malaria antigen detection assays), incorporate rapid diagnostics. RDTs find extensive use in screening, epidemiology, patient management, and diagnosis. The market expansion is primarily driven by the increased demand for quick diagnostic tests in decentralized settings and growing public awareness of the benefits of early diagnosis. Moreover, the market is expected to grow due to the rising demand for accurate diagnostic tests at affordable prices. However, the growth of the quick diagnostics market is hindered by consumer unawareness of newer rapid diagnostic tests available in the market. Nevertheless, the market for quick diagnostics is expected to benefit from the increasing demand for bedside diagnostic testing. The point-of-care rapid diagnostics market encompasses a range of testing tools, including glucose monitoring kits, pregnancy and fertility testing kits, infectious disease testing kits, urinalysis testing kits, haematological testing kits, cardiometabolic monitoring kits, and similar tools. These tests are utilized in hospitals, professional clinics, and private residences. Market growth in the point-of-care and rapid diagnostics sector is primarily driven by the high prevalence of infectious diseases, supportive government policies, and an increasing number of CLIA-waived POC tests.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Diagnostics Market Segmental Analysis

The Global Rapid diagnostics market is segmented on the basis of product, platform, end use, application, and region. By product, the market is segmented into kits and equipment. By platform, the market is segmented into Immunoassays, Molecular Detection and other platforms. By end use, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care/Self Testing, and Other End Users. By application, the market is segmented into Infectious Diseases Testing , Pregnancy & Fertility Testing, Cardiac Metabolism Testing, Cholesterol Testing, Tumor/Cancer Markers Testing, Blood Glucose Testing, Urinalysis, Hematology Testing, Other Tests. By Region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and MEA.

Drivers of the Global Rapid Diagnostics Market

The increasing prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and various infectious diseases has become notably prominent. This rise in chronic illnesses is a key factor driving the demand for point-of-care diagnostics during the anticipated timeframe. Globally, the frequency of diabetes and other chronic diseases has seen a significant increase, resulting in a higher demand for quick point-of-care diagnostics to effectively treat these conditions. This trend is expected to contribute to favorable global market growth for point-of-care diagnostics.

Restraints in the Global Rapid Diagnostics Market

The lack of accuracy in rapid point-of-care diagnostic tests worldwide, coupled with the low number of FDA approvals for rapid testing, has hindered the growth of the entire industry due to the high cost associated with virus clearing technology. The field of point-of-care testing is susceptible to pre-analytical errors, which may limit the introduction of new products and impede market growth. For instance, Siemens Healthcare issued a Class 2 Device Recall for their BGEM Analyze Card In-vitro Diagnostic Device in August 2020 due to conflicting glucose results on card lot 01-20095-10. Such inconsistencies can delay the diagnosis of hyperglycemia or result in unnecessary hypoglycemia treatment. Consequently, during the projected period, the lack of precision in point-of-care testing is expected to restrict market expansion on a global scale.

Market Trends of the Global Rapid Diagnostics Market

Key market players are increasingly focusing on integrating cutting-edge technologies such as artificial intelligence to develop effective point-of-care diagnostics. Advancements in lab-on-a-chip platforms, wearable technology, and breakthroughs in smartphone-based technologies have led to significant enhancements in point-of-care testing (POCT) devices. The implementation of deep learning systems on the cloud has paved the way for upcoming disruptions. Additionally, advancements in novel biosensors, microfluidics, and chip technology miniaturization have propelled the development of new diagnostic systems. Lab-on-a-chip technology, particularly in the detection of infectious diseases, is a significant driver of POCT advancements. Various bioassays, including microbiological culture, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR), can now be conducted at the point of care, thanks to lab-on-a-chip technology. As a result, the adoption of new technologies for manufacturing point-of-care testing kits is expected to bolster global market growth during the forecast period.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Rapid Diagnostics Market by product

Market Overview
kits and equipment

Global Rapid Diagnostics Market by platform

Market Overview
Immunoassays
Molecular Detection and other platform

Global Rapid Diagnostics Market by End use

Market Overview
Hospitals & Clinics
Diagnostic Laboratories
Home Care/Self Testing
and Other End Users

Global Rapid Diagnostics Market by Application

Market Overview
Infectious Diseases Testing
Pregnancy & Fertility Testing
Cardiac Metabolism Testing
Cholesterol Testing
Tumour/Cancer Markers Testing
Blood Glucose Testing
Urinalysis
Hematology Testing
Other Tests

Global Rapid Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMA(C)rieux S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Scientific Designs, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BTNX Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
and Trinity Biotech plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments